U
Attovia Therapeutics, Inc. ATTO
$19.49 $0.311.59% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 03/31/2025
Total Cash And Short-Term Investments 132.62M 69.32M
Total Receivables 700.00K --
Inventory -- --
Prepaid Expenses 3.32M --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 136.64M --

Total Current Assets 136.64M --
Net Property, Plant & Equipment 7.49M --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 1.95M --
Total Assets 146.09M --

Total Accounts Payable 2.53M --
Total Accrued Expenses 4.84M --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 1.98M --
Total Finance Division Other Current Liabilities 450.00K --
Total Other Current Liabilities 450.00K --
Total Current Liabilities 9.80M --

Total Current Liabilities 9.80M --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 2.83M --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 750.00K --
Total Liabilities 13.38M --

Common Stock & APIC 4.18M --
Retained Earnings -129.67M --
Treasury Stock & Other -27.00K --
Total Common Equity -125.52M -46.83M

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 258.23M --
Preferred Stock, Others -- --
Total Preferred Equity 258.23M 108.95M

Total Common Equity -125.52M -46.83M
Total Preferred Equity 258.23M 108.95M
Total Minority Interest -- --
Total Equity 132.71M 62.13M